We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to gen... Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Show more
LAWRENCEVILLE, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and...
Proof-of-concept study for Imunon’s first vaccine utilizing its proprietary PlaCCine platform is now open for enrollment Topline results expected this year LAWRENCEVILLE, N.J., May 13, 2024...
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on...
Assumes leadership role as Company anticipates multiple near-term clinical milestones Brings extensive leadership and experience in drug development and business strategy LAWRENCEVILLE, N.J., May...
LAWRENCEVILLE, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.12 | -7.89473684211 | 1.52 | 1.54 | 1.28 | 36129 | 1.39030452 | CS |
4 | 0.31 | 28.4403669725 | 1.09 | 1.57 | 1.09 | 46873 | 1.35748754 | CS |
12 | 0.83 | 145.614035088 | 0.57 | 2 | 0.5602 | 227457 | 1.26785755 | CS |
26 | 0.48 | 52.1739130435 | 0.92 | 2 | 0.48 | 137510 | 1.13903634 | CS |
52 | 0.15 | 12 | 1.25 | 2 | 0.48 | 80939 | 1.14783436 | CS |
156 | -0.56 | -28.5714285714 | 1.96 | 2 | 0.48 | 70208 | 1.24558611 | CS |
260 | -0.56 | -28.5714285714 | 1.96 | 2 | 0.48 | 70208 | 1.24558611 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions